# FDA Warning Letter: Furley Bioextracts SDN BHD
> 2021-09-21 · Center for Drug Evaluation and Research | CDER · `99342823a6a5ac74`
## Letter
- **Company:** Furley Bioextracts SDN BHD
- **Posted Date:** 2021-09-21
- **Letter Issue Date:** 2021-09-13
- **Issuing Office:** Center for Drug Evaluation and Research | CDER
## Subject
CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*